Skip to main content

Animations

MJFF Publications

3261 - 3270 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2009
  • 2022
  • 2017
  • 2016
  • 2017
  • 2023
  • 2017
  • 2021
  • 2024
  • Summary Details
    RESTRICTED
    Title: Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose
    Journal Name: Journal of Pharmaceutical and Biomedical Analysis
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jpba.2019.07.014
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356
    Citation Count: 408
  • Summary Details
    OPEN
    Title: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2112712119
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002
    Citation Count: 82
  • Summary Details
    RESTRICTED
    Title: How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.027
    Citation Count: 162
  • Summary Details
    OPEN
    Title: MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.020
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Two‐Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individuals
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15733
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: multiplierz v2.0: A Python‐based ecosystem for shared access and analysis of native mass spectrometry data
    Journal Name: PROTEOMICS
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/pmic.201700091
    Citation Count: 50
  • Summary Details
    OPEN
    Title: CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awab103
    Citation Count: 245
  • Summary Details
    OPEN
    Title: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.26923
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.